# Single Dose Crossover Study to Compare the Respiratory Drive After Administration of Belbuca, Oxycodone and Placebo.

> **NCT03996694** · PHASE1 · COMPLETED · sponsor: **BioDelivery Sciences International** · enrollment: 19 (actual)

## Conditions studied

- Respiratory Depression

## Interventions

- **DRUG:** Belbuca 300 µg
- **DRUG:** Belbuca 600 µg
- **DRUG:** Belbuca 900 µg
- **DRUG:** Oxycodone 30 mg
- **DRUG:** Oxycodone 60 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03996694
- **Lead sponsor:** BioDelivery Sciences International
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-23
- **Primary completion:** 2019-10-27
- **Final completion:** 2019-10-27
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2021-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03996694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03996694, "Single Dose Crossover Study to Compare the Respiratory Drive After Administration of Belbuca, Oxycodone and Placebo.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03996694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*